Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hA-MSCs in Premature Ovarian Insufficiency
NCT07115082Phase 2Recruiting
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human adipose-derived mesenchymal stem cells for injection in premature ovarian insufficiency (POI). Started Oct 2024; status: recruiting.
02
Drugs
human adipose-derived mesenchymal stem cells for injection
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07115082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07115082.